Active Aβ immunotherapy CAD106 in Alzheimer's disease: A phase 2b study

Rik Vandenberghe, Marie Emmanuelle Riviere, Angelika Caputo, Judit Sovago, R. Paul Maguire, Martin Farlow, Giovanni Marotta, Raquel Sanchez-Valle, Philip Scheltens, J. Michael Ryan, Ana Graf

Research output: Contribution to journalArticle

36 Scopus citations

Fingerprint Dive into the research topics of 'Active Aβ immunotherapy CAD106 in Alzheimer's disease: A phase 2b study'. Together they form a unique fingerprint.

Medicine & Life Sciences